Skip to content
2000
Volume 24, Issue 14
  • ISSN: 1389-4501
  • E-ISSN: 1873-5592

Abstract

Experimental inhibition of the (pro)renin receptor [(P)RR] is a promising therapeutic strategy in different disease models ranging from cardiorenal to oncological entities. Here, we briefly review the direct protein-protein interaction partners of the (P)RR and the plethora of distinct diseases in which the (P)RR is involved.The first structural work on the (P)RR using AlphaFold, which was recently published by Ebihara et al., is the center of this mini-review since it can mechanistically link the protein-protein interaction level with the pathophysiological level.More detailed insights into the 3D structure of the (P)RR and its interaction domains might guide drug discovery on this novel target. Finally, antibody- and small molecule-based approaches to inhibit the (P)RR are shortly discussed.

Loading

Article metrics loading...

/content/journals/cdt/10.2174/0113894501250617231016052930
2023-10-01
2025-06-12
Loading full text...

Full text loading...

/content/journals/cdt/10.2174/0113894501250617231016052930
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test